H
Hybio Pharmaceutical
Shenzhen Hybio Pharmaceutical is a high-tech enterprise which engaged in research, development, production, and sales of polypeptide drugs
About Hybio Pharmaceutical
Hybio Pharmaceutical Co., Ltd. is a high-tech enterprise focused on the research, development, and manufacturing of a wide range of peptide products. Established in 1998, Hybio has grown to become one of the largest and most professional peptide pharmaceutical companies in China. The company operates in the pharmaceutical industry, specifically targeting the peptide sector, which involves short chains of amino acids used in various medical treatments. Hybio serves a diverse clientele, including hospitals, research institutions, and pharmaceutical companies, both domestically and internationally.
Read full description
Hybio's business model revolves around the production and sale of peptide finished dosage products, peptide active pharmaceutical ingredients (APIs), and providing contract research and manufacturing services (CRO/CMO). The company generates revenue through the direct sale of its peptide products and by offering specialized services to other pharmaceutical companies.
Hybio's market presence is bolstered by its comprehensive product range and its commitment to innovation and quality. The company has received numerous accolades, including being listed in Forbes China and winning the Shield Award. Hybio's participation in global events such as the AAPS Annual Meeting and CPHI Worldwide further underscores its prominence in the industry.
At a glance
- Founded
- 1998
- Headquarters
- Shenzhen, China
- Listing
- IPO 2011
- Sector
- Biotech & Life Sciences
- Power Law
- Thoroughbred$100M+ revenue
Latest news
Press, funding announcements and product moves mentioning Hybio Pharmaceutical.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Market sentiment
An AI-synthesised read of the highest-engagement posts about Hybio Pharmaceutical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Hybio Pharmaceutical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.